170 related articles for article (PubMed ID: 34185954)
21. Response of intraductal carcinoma of the prostate to androgen deprivation therapy predicts prostate cancer prognosis in radical prostatectomy patients.
Kato M; Hirakawa A; Kobayashi Y; Yamamoto A; Ishida R; Kamihira O; Sano T; Majima T; Ishida S; Funahashi Y; Sassa N; Fujita T; Matsukawa Y; Hattori R; Gotoh M; Tsuzuki T
Prostate; 2020 Feb; 80(3):284-290. PubMed ID: 31860754
[TBL] [Abstract][Full Text] [Related]
22. Clinical utility of intraductal carcinoma of the prostate in treatment selection for metastatic hormone-sensitive prostate cancer.
Naito Y; Kato M; Kawanishi H; Yamamoto A; Sakamoto F; Hirabayashi H; Kobayashi M; Matsukawa Y; Kimura T; Araki H; Nishikimi T; Kondo A; Yoshino Y; Hashimoto Y; Nakano Y; Tsuzuki T
Prostate; 2023 Mar; 83(4):307-315. PubMed ID: 36420892
[TBL] [Abstract][Full Text] [Related]
23. [A Case of BRCA2 Mutation-Positive Intraductal Carcinoma of the Prostate].
Doi K; Fujii T; Hanamoto M; Takamura K; Nakada T; Sato Y; Ogura K
Hinyokika Kiyo; 2023 Jul; 69(7):189-192. PubMed ID: 37558640
[TBL] [Abstract][Full Text] [Related]
24. PTEN loss in prostatic adenocarcinoma correlates with specific adverse histologic features (intraductal carcinoma, cribriform Gleason pattern 4 and stromogenic carcinoma).
Shah RB; Shore KT; Yoon J; Mendrinos S; McKenney JK; Tian W
Prostate; 2019 Aug; 79(11):1267-1273. PubMed ID: 31111513
[TBL] [Abstract][Full Text] [Related]
25. Intraductal Carcinoma of the Prostate: Pathogenesis and Molecular Perspectives.
Zong Y; Montironi R; Massari F; Jiang Z; Lopez-Beltran A; Wheeler TM; Scarpelli M; Santoni M; Cimadamore A; Cheng L
Eur Urol Focus; 2021 Sep; 7(5):955-963. PubMed ID: 33132109
[TBL] [Abstract][Full Text] [Related]
26. Comedonecrosis within conventional prostatic adenocarcinoma vs. intraductal carcinoma of the prostate: their clinical significance is not comparable.
Wang Y; Teramoto Y; Miyamoto H
Hum Pathol; 2023 Aug; 138():112-120. PubMed ID: 37364826
[TBL] [Abstract][Full Text] [Related]
27. Intraductal Carcinoma of the Prostate on Diagnostic Needle Biopsy Predicts Prostate Cancer Mortality: A Population-Based Study.
Saeter T; Vlatkovic L; Waaler G; Servoll E; Nesland JM; Axcrona K; Axcrona U
Prostate; 2017 Jun; 77(8):859-865. PubMed ID: 28240424
[TBL] [Abstract][Full Text] [Related]
28.
Warner E; Herberts C; Fu S; Yip S; Wong A; Wang G; Ritch E; Murtha AJ; Vandekerkhove G; Fonseca NM; Angeles A; Beigi A; Schönlau E; Beja K; Annala M; Khalaf D; Chi KN; Wyatt AW
Clin Cancer Res; 2021 Mar; 27(6):1650-1662. PubMed ID: 33414135
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of the presence of intraductal carcinoma of the prostate and bone metastasis in needle biopsy for prostate carcinoma patients with Grade Group 5.
Chen X; Yang Y; Wang W; Han B; Qi M; Geng S; Xu J; Zhang Q; Wang X; Chen S; Shi K; Ke X; Zhang J
Pathol Res Pract; 2020 Jan; 216(1):152693. PubMed ID: 31734052
[TBL] [Abstract][Full Text] [Related]
30. Prognostic parameter for high risk prostate cancer patients at initial presentation.
Kato M; Kimura K; Hirakawa A; Kobayashi Y; Ishida R; Kamihira O; Majima T; Funahashi Y; Sassa N; Matsukawa Y; Hattori R; Gotoh M; Tsuzuki T
Prostate; 2018 Jan; 78(1):11-16. PubMed ID: 29094384
[TBL] [Abstract][Full Text] [Related]
31. PTEN loss in intraductal carcinoma of the prostate has low incidence in Japanese patients.
Ito T; Takahara T; Taniguchi N; Yamamoto Y; Satou A; Ohashi A; Takahashi E; Sassa N; Tsuzuki T
Pathol Int; 2023 Nov; 73(11):542-548. PubMed ID: 37608749
[TBL] [Abstract][Full Text] [Related]
32. The presence and clinical implication of intraductal carcinoma of prostate in metastatic castration resistant prostate cancer.
Chen Z; Chen N; Shen P; Gong J; Li X; Zhao T; Liao B; Liu L; Liu Z; Zhang X; Liu J; Peng Z; Chen X; Xu M; Gui H; Zhang P; Wei Q; Zhou Q; Zeng H
Prostate; 2015 Sep; 75(12):1247-54. PubMed ID: 25917338
[TBL] [Abstract][Full Text] [Related]
33. Transcriptomic Features of Cribriform and Intraductal Carcinoma of the Prostate.
Lone Z; Benidir T; Rainey M; Nair M; Davicioni E; Gibb EA; Williamson S; Gupta S; Chaim Ornstein M; Tendulkar R; Weight C; Nguyen JK; Klein EA; Mian OY
Eur Urol Focus; 2022 Nov; 8(6):1575-1582. PubMed ID: 35662504
[TBL] [Abstract][Full Text] [Related]
34. The influence of the presence of intraductal carcinoma of the prostate on the grade group system's prognostic performance.
Kato M; Hirakawa A; Kobayashi Y; Yamamoto A; Ishida R; Sano T; Kimura T; Majima T; Ishida S; Funahashi Y; Sassa N; Fujita T; Matsukawa Y; Yamamoto T; Hattori R; Gotoh M; Tsuzuki T
Prostate; 2019 Jul; 79(10):1065-1070. PubMed ID: 31025722
[TBL] [Abstract][Full Text] [Related]
35. Clinical significance of IDC-P as predictive factor after intensity-modulated radiation therapy.
Aizawa R; Tsuzuki T; Haga H; Nakamura K; Ogata T; Inoue T; Kobayashi T; Akamatsu S; Goto T; Ogawa O; Mizowaki T
Cancer Sci; 2022 Jul; 113(7):2425-2433. PubMed ID: 35514196
[TBL] [Abstract][Full Text] [Related]
36. Heterogeneous clinicopathological features of intraductal carcinoma of the prostate: a comparison between "precursor-like" and "regular type" lesions.
Miyai K; Divatia MK; Shen SS; Miles BJ; Ayala AG; Ro JY
Int J Clin Exp Pathol; 2014; 7(5):2518-26. PubMed ID: 24966964
[TBL] [Abstract][Full Text] [Related]
37. Concomitant intraductal carcinoma of the prostate and response to hormonal therapy in metastatic prostate carcinoma.
Abascal-Junquera JM; Fumadó-Ciutat L; Gasa-Galmes B; Costa-Planells M; Munarriz-Polo M; Sanromà-Salvà A; Polaina-Barroso L; Solà-Marqués C; Juanpere-Rodero N; Lloreta-Trull J; Cecchini-Rosell L
Actas Urol Esp (Engl Ed); 2021; 45(6):455-460. PubMed ID: 34147428
[TBL] [Abstract][Full Text] [Related]
38. Distinction between intraductal carcinoma of the prostate (IDC-P), high-grade dysplasia (PIN), and invasive prostatic adenocarcinoma, using molecular markers of cancer progression.
Dawkins HJ; Sellner LN; Turbett GR; Thompson CA; Redmond SL; McNeal JE; Cohen RJ
Prostate; 2000 Sep; 44(4):265-70. PubMed ID: 10951489
[TBL] [Abstract][Full Text] [Related]
39. Atypical Intraductal Cribriform Proliferations of the Prostate Exhibit Similar Molecular and Clinicopathologic Characteristics as Intraductal Carcinoma of the Prostate.
Hickman RA; Yu H; Li J; Kong M; Shah RB; Zhou M; Melamed J; Deng FM
Am J Surg Pathol; 2017 Apr; 41(4):550-556. PubMed ID: 28009609
[TBL] [Abstract][Full Text] [Related]
40. [SIGNIFICANCE OF INTRADUCTAL CARCINOMA OF THE PROSTATE IN POST-OPERATIVE BIOCHEMICAL RECURRENCE].
Sakamoto N; Ueda S; Mizoguchi H; Kawahara I; Kobayashi T; Hamaguchi M; Yoshikawa M
Nihon Hinyokika Gakkai Zasshi; 2017; 108(1):5-11. PubMed ID: 29367511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
